Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
17 hedge funds and large institutions have $1.59M invested in Zosano Pharma Corporation in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 8 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
23% less funds holding
Funds holding: 22 → 17 (-5)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
75% less capital invested
Capital invested by funds: $6.3M → $1.59M (-$4.71M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highlander Capital Management
Short Hills,
New Jersey
|
+$144K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$57.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$48.7K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$14.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$8.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.42M |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$1.15M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$681K |
| 4 |
NC
Nexthera Capital
New York
|
-$309K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$197K |
ZSAN Hedge Fund Activity: Q4 2017 in Review
17 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q4 2017, worth a combined $1.59M — down 75% from $6.3M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ZSAN and 4 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Highlander Capital Management, opening a new position worth an estimated $144K. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.42M sold.
- 17 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q4 2017, down from 22 in Q3 2017.
- Funds reported $1.59M of Zosano Pharma Corporation stock for Q4 2017, down 75% quarter-over-quarter.
- 4 funds opened new Zosano Pharma Corporation positions in Q4 2017 and 8 closed out, a net change of -4 holders.
- The largest Zosano Pharma Corporation buyer in Q4 2017 was Highlander Capital Management, an estimated $144K added.
- The largest Zosano Pharma Corporation seller in Q4 2017 was Fidelity Investments, an estimated $1.42M sold.
Based on aggregated 13F filings for Q4 2017.